We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Collaboration on Cardiac Stem Cell Research

By Biotechdaily staff writers
Posted on 05 Nov 2003
An agreement to collaborate on stem cell research aimed at naturally replacing diseased and damaged heart tissue and thus reducing or eliminating the need for artificial devices and heart transplants has been signed by the Technion-Israel Institute of Technology (Haifa, Israel) and the Cleveland Clinic (Ohio, USA). More...
The two institutions will jointly develop and use stem cell technology to regenerate heart tissue and explore other medical advances, including robotics.

Research has shown that under the correct conditions the body's own stem cells can be made to travel to the heart and differentiate into blood vessels. Goals of the joint project are to ensure correct recruitment of stem cells from the bone marrow and to optimize the conditions for differentiation into cardiac myocytes. The collaborators will also work on a number of other projects. These include designing an artificial cartilage that mimics true cartilage when implanted, developing an ultrasound-based method to help patients with congestive heart failure by determining where to attach lead lines for devices, developing a miniature robotic device with a camera to give orthopedic surgeons a better view of damaged areas, and finding new ways to use robotic technology in implanting lumbar screws during back surgery.

"Everyone is very excited,” said Christopher Coburn, head of the Cleveland Clinic's technology commercialization division and a member of the steering committee overseeing the collaboration. "These initial projects were selected because of the potential early-term clinical applications.”




Related Links:
Cleveland Clinic
Technion

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.